# Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease

> **NCT05997043** · EARLY_PHASE1 · RECRUITING · sponsor: **Zhujiang Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson's Disease
- Overactive Bladder
- Onabotulinumtoxin A

## Interventions

- **DRUG:** oral anti-Parkinson drugs and injection of botulinum toxin
- **DRUG:** oral anti-Parkinson's drugs

## Key facts

- **NCT ID:** NCT05997043
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-26
- **Primary completion:** 2024-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05997043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05997043, "Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05997043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*